Assessment of the glycemic responses to nutritional products
- Conditions
- ot applicable
- Registration Number
- NL-OMON22371
- Lead Sponsor
- Danone Nutricia Research
- Brief Summary
not applicable
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 10
1.Age = 18 and = 60 years
2.Body Mass Index (BMI) = 18.5 and = 24.9 kg/m2
3.Written informed consent
4.Willingness and ability to comply with the protocol
5.Judged by the investigator to be in good health
1.Known Diabetes Mellitus type I or type II, rebound hypoglycaemia and/or any other medical condition that interferes with glucose
2.Any use of anticoagulants, steroids, protease inhibitors or antipsychotics and/or any medication known to affect glucose tolerance and/or to influence digestion and absorption of nutrients within 1 week of screening, in opinion of the investigator
3.Any known disease which influence digestion and absorption of nutrients within 1 week of screening
4.Any known relevant food allergy or intolerance
5.Adherence to a strict vegan diet and/or a weight loss program
6.Any known bleeding disorder
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary outcome is the glycemic index of the test products
- Secondary Outcome Measures
Name Time Method The secondary outcome parameters in this study are:<br>-GL=GI*available carbohydrate/given amount<br>Capillary blood glucose mmol/l and iAUC0-120 [mmol/l*min] of the reference product and test product(s)<br>-Capillary blood glucose iCmax [mmol/l] and Tmax [min] of the reference product and test product(s)<br>-Appetite profile and liking of the test product using visual analogue scales (VAS, mm)